Form 4: Mirum Pharmaceuticals CFO Sells Shares
Insider Transaction (Form 4)
Eric Bjerkholt, CHIEF FINANCIAL OFFICER of Mirum Pharmaceuticals, Inc., sold 6,001 shares of common stock on August 11, 2026 for $99.90 per share.
Summary
- Open-market sale: disposed of 6,001 Common Stock at $99.90 ($599,510) on August 11, 2026; holds 36,355 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $599,510 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Eric Bjerkholt — Officer (CHIEF FINANCIAL OFFICER)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Open-market sale | Common Stock | 6,001 | $100 | $599.5K | 36,355 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Open-market sale (6,001 shares) |
Keywords
insider transaction, Form 4, MIRM, Mirum Pharmaceuticals, Inc., bearish, Eric Bjerkholt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.